ライフサイエンスコーパス: bone morphogenetic

1 ly, mutations in the gene for the proteinase bone morphogenetic 1 (BMP1) were reported in two recessi

2 Our aim was to delineate the role of bone morphogenetic protein (BMP) 2 signaling in lymphati

3 l ectoderm (PPE) that requires inhibition of bone morphogenetic protein (BMP) and expresses the key r

4 Here, we show how Bone Morphogenetic Protein (BMP) and Fibroblast Growth F

5 Here, we show that opposing gradients of bone morphogenetic protein (BMP) and Nodal, two transfor

6 y 2 signaling pathways: the "iron-regulated" bone morphogenetic protein (BMP) and the inflammatory JA

7 We found that modulation of bone morphogenetic protein (BMP) and WNT signaling combi

8 t in the context of reduced ShcA levels, the bone morphogenetic protein (BMP) antagonist chordin-like

9 We demonstrate here that expression of the bone morphogenetic protein (BMP) antagonist gremlin 1 de

10 We have recently shown that the bone morphogenetic protein (BMP) antagonist Gremlin 2 (G

11 This is due to induction of the bone morphogenetic protein (BMP) antagonist Gremlin-1, a

12 GREMLIN 2 (GREM2) is a strong bone morphogenetic protein (BMP) antagonist that is know

13 expression of chordin (chd), which encodes a bone morphogenetic protein (BMP) antagonist that is loca

14 cted gene aberrant in neuroblastoma (DAN), a bone morphogenetic protein (BMP) antagonist we detected

15 e that CHRDL1 encodes Ventroptin, a secreted bone morphogenetic protein (BMP) antagonist, the molecul

16 We further identified bone morphogenetic protein (BMP) as a candidate myocardi

17 Hemojuvelin is a bone morphogenetic protein (BMP) co-receptor.

18 The bone morphogenetic protein (Bmp) family of secreted mole

19 The Bone Morphogenetic Protein (BMP) family reiteratively si

20 Distinct pools of the bone morphogenetic protein (BMP) Glass bottom boat (Gbb)

21 iron homeostasis by direct interaction with bone morphogenetic protein (BMP) ligands to induce hepci

22 that injury stimulates the production of two bone morphogenetic protein (BMP) ligands, Dpp and Gbb, w

23 Smad transcription factors critical for the bone morphogenetic protein (BMP) pathway and the DNA rep

24 Mutations in the Bone Morphogenetic Protein (BMP) pathway are associated

25 equencing (ChIP-seq) data, we identified the bone morphogenetic protein (BMP) pathway as a potential

26 Here we demonstrate that the bone morphogenetic protein (BMP) pathway can also be reg

27 ion and specific decreased expression of the bone morphogenetic protein (BMP) pathway component Mad.

28 Fine-tuning of the bone morphogenetic protein (BMP) pathway is essential fo

29 At diagnosis, deregulation of the bone morphogenetic protein (BMP) pathway is involved in

30 in particular the dual modulation of Wnt and bone morphogenetic protein (BMP) pathway signaling, this

31 on the transforming growth factor (TGF)-beta/bone morphogenetic protein (BMP) pathway, which is one o

32 ess of endodermal development, including the Bone morphogenetic protein (Bmp) pathway.

33 ransforming growth factor beta (TGFbeta) and bone morphogenetic protein (BMP) pathways.

34 Beta-catenin/Tcf and the TGF-beta bone morphogenetic protein (BMP) provide critical molecu

35 The bone morphogenetic protein (BMP) receptor Tkv localizes

36 14-17 of CRIM1 (cysteine-rich transmembrane bone morphogenetic protein (BMP) regulator 1).

37 ly in mice, which specify germ cells through bone morphogenetic protein (BMP) signal-mediated inducti

38 red neogenic hair follicles, which triggered bone morphogenetic protein (BMP) signaling and then acti

39 ects of Matn3 on chondrocyte hypertrophy and bone morphogenetic protein (Bmp) signaling by quantifyin

40 We showed previously that SMOC inhibits bone morphogenetic protein (BMP) signaling downstream of

41 Loss of the growth-suppressive effects of bone morphogenetic protein (BMP) signaling has been demo

42 Bone Morphogenetic Protein (BMP) signaling has been impl

43 To investigate the role of bone morphogenetic protein (BMP) signaling in osteoclast

44 hem, a source of Wingless-related (WNT) and bone morphogenetic protein (BMP) signaling in the dorsom

45 result of differential regulation of Wnt and bone morphogenetic protein (BMP) signaling in these two

46 has been constructed and, here, we show that bone morphogenetic protein (BMP) signaling is essential

47 We have investigated whether bone morphogenetic protein (BMP) signaling is involved i

48 Here we show that hippocampal bone morphogenetic protein (BMP) signaling is modulated

49 While it has been demonstrated that bone morphogenetic protein (Bmp) signaling is required f

50 The bone morphogenetic protein (BMP) signaling pathway compr

51 ibit Ras signaling and may also activate the bone morphogenetic protein (BMP) signaling pathway in co

52 IL-1beta activated the bone morphogenetic protein (BMP) signaling pathway in he

53 coagulation factor fibrinogen activates the bone morphogenetic protein (BMP) signaling pathway in ol

54 We previously reported that the bone morphogenetic protein (BMP) signaling pathway is cr

55 In the adult Drosophila midgut the bone morphogenetic protein (BMP) signaling pathway is re

56 The bone morphogenetic protein (BMP) signaling pathway regul

57 Hepcidin expression is induced via the bone morphogenetic protein (BMP) signaling pathway that

58 rates that RNAi silencing of a member of the Bone Morphogenetic Protein (BMP) signaling pathway, Deca

59 er, SMAD4 is also a central component of the bone morphogenetic protein (BMP) signaling pathway, impl

60 f these mutants target the components of the Bone Morphogenetic Protein (BMP) signaling pathway, reve

61 The bone morphogenetic protein (BMP) signaling pathways have

62 ls (DCDMLs), we investigated how the FGF and bone morphogenetic protein (BMP) signaling pathways posi

63 axis is established and patterned by Wnt and bone morphogenetic protein (BMP) signaling pathways, res

64 A morphogen gradient of Bone Morphogenetic Protein (BMP) signaling patterns the

65 Bone morphogenetic protein (BMP) signaling plays a key r

66 between transforming growth factor beta1 and bone morphogenetic protein (BMP) signaling plays an impo

67 Bone morphogenetic protein (BMP) signaling plays many ro

68 Inhibition of bone morphogenetic protein (BMP) signaling prevents the

69 The family of TGF-beta and bone morphogenetic protein (BMP) signaling proteins has

70 Bone morphogenetic protein (BMP) signaling regulates ear

71 Bone morphogenetic protein (BMP) signaling was activated

72 Although antagonists of bone morphogenetic protein (BMP) signaling, such as Nogg

73 elf-renewing SCs, Foxc1 activates Nfatc1 and bone morphogenetic protein (BMP) signaling, two key mech

74 per, notable for roles in Wingless (Wnt) and bone morphogenetic protein (BMP) signaling, were differe

75 al in the Drosophila ovary where it enhances bone morphogenetic protein (BMP) signaling.

76 TGF-beta and activin signals while enhancing bone morphogenetic protein (BMP) signaling.

77 cell (SC), grows selectively in response to bone morphogenetic protein (BMP) signaling.

78 and VEGF-A, which is indicative of increased bone morphogenetic protein (BMP) signaling.

79 ontrolling iron homeostasis, is regulated by bone morphogenetic protein (BMP) signaling.

80 molecule (RGM)-mediated axon guidance and in bone morphogenetic protein (BMP) signaling.

81 wingless-related integration site (WNT), and bone morphogenetic protein (BMP) signalling interactions

82 reveals that complementary components of the bone morphogenetic protein (BMP) signalling pathway are

83 s myocardial trabeculation through Erbb2 and bone morphogenetic protein (BMP) signalling, we discover

84 pression and signaling are up-regulated, and bone morphogenetic protein (BMP) signals are impaired.

85 rfamily of signaling pathways, including the bone morphogenetic protein (BMP) subfamily of ligands an

86 c mathematical model of tissue genesis using bone morphogenetic protein (BMP) to represent of a class

87 and Wnt/beta-catenin) or share (TGFbeta and bone morphogenetic protein (BMP)) core signaling compone

88 This data shows that Wnt, bone morphogenetic protein (BMP), and fibroblast growth

89 ys, epidermal growth factor receptor (EGFR), bone morphogenetic protein (BMP), Jun kinase (JNK), JAK/

90 dels commonly increase signaling of the Wnt, bone morphogenetic protein (BMP), or Ras/ERK pathways, c

91 FE) is specified by sequential inhibition of bone morphogenetic protein (BMP), transforming growth fa

92 ial cells (recell-dTBs); 3) dTBs seeded with bone morphogenetic protein (BMP)-2 (dTB-BMPs); and 4) fr

93 Bone morphogenetic protein (BMP)-2 is used clinically fo

94 owth factor (TGF)-beta family, TGF-beta1 and bone morphogenetic protein (BMP)-2, in synovial fibrobla

95 Hyperactivation of the bone morphogenetic protein (BMP)-ACVR1 developmental pat

96 sly, we demonstrated that transplantation of bone morphogenetic protein (BMP)-induced astrocytes deri

97 luence transcriptional regulation within the bone morphogenetic protein (BMP)-signaling pathway.

98 which is transcriptionally regulated by the bone morphogenetic protein (BMP)-SMAD pathway.

99 The bone morphogenetic protein (BMP)-SMAD signaling pathway

100 in chicken embryos to demonstrate a role for bone morphogenetic protein (BMP)/SMA and MAD related (Sm

101 The bone morphogenetic protein (BMP)/SMAD signaling pathway

102 ad2/3 pathway and activation of the parallel bone morphogenetic protein (BMP)/Smad1/5 axis (recently

103 was accompanied by changes in expression of bone morphogenetic protein (BMP)/sons of mothers against

104 ymatic activity, and six were members of the bone morphogenetic protein (BMP)/TGF-beta pathway.

105 Bone morphogenetic protein (BMP)4 is a mesenchymal pepti

106 es the gene encoding hepcidin (HAMP) via the bone morphogenetic protein (BMP)6 signaling to SMAD.

107 Bone morphogenetic protein (BMP)9 is a circulating growt

108 C1s, sea urchin epidermal growth factor, and bone morphogenetic protein (CUB) domains of uncertain fu

109 s of VBA, with and without recombinant human bone morphogenetic protein (rhBMP)-2, under space-making

110 hyperactive transforming growth factors beta/bone morphogenetic protein (TGFbeta/BMP) signaling in dK

111 These nonanticoagulant compounds impair bone morphogenetic protein /sons of mothers against deca

112 bsence of the type I collagen C-propeptidase bone morphogenetic protein 1 (BMP1) causes type XII oste

113 Mutations in bone morphogenetic protein 1 (BMP1) in humans or deletio

114 es the cleavage of C-terminal procollagen by bone morphogenetic protein 1 (BMP1).

115 Growth differentiation factor 9 (GDF9) and bone morphogenetic protein 15 (BMP15) are secreted durin

116 io of growth differentiation factor 9 (GDF9):bone morphogenetic protein 15 (BMP15) at diestrus.

117 terms of osteoblastic differentiation using bone morphogenetic protein 2 (BMP-2) added to the medium

118 d a positive effect of tissue-derived BGN on bone morphogenetic protein 2 (BMP-2) function, which is

119 Parbendazole up-regulates bone morphogenetic protein 2 (BMP-2) gene expression and

120 Although bone morphogenetic protein 2 (BMP-2) is known to stimula

121 The expressions of bone morphogenetic protein 2 (BMP2) and BMP6; sex-determ

122 study, we discovered the double deletion of bone morphogenetic protein 2 (Bmp2) and bone morphogenet

123 ation of an injectable and porous nCS/A with bone morphogenetic protein 2 (BMP2) gene-modified MSCs a

124 Bone morphogenetic protein 2 (BMP2) in chromosomal regio

125 Bone morphogenetic protein 2 (BMP2) promotes PF formatio

126 n of smooth muscle contractions by secreting bone morphogenetic protein 2 (BMP2), which activates BMP

127 Recombinant human bone morphogenetic protein 2 (rhBMP-2) has been used for

128 ptide nanostructures amplified signalling of bone morphogenetic protein 2 significantly more than the

129 phogen action during animal development, the bone morphogenetic protein 2/4 (BMP2/4)-like ligand Deca

130 infection and transcript analysis identified bone morphogenetic protein 4 (BMP4) as a candidate endot

131 Bone morphogenetic protein 4 (BMP4) has potential as an

132 n of bone morphogenetic protein 2 (Bmp2) and bone morphogenetic protein 4 (Bmp4) in the dental epithe

133 response to transient (24-36 h) exposure to bone morphogenetic protein 4 (BMP4) plus inhibitors of A

134 coprotein 1 (GLG1) expression and downstream bone morphogenetic protein 4 (BMP4) signaling and also r

135 es different concentrations of activin A and bone morphogenetic protein 4 (BMP4) to polarize cells in

136 TGF-beta signaling mediated by pSMAD2, bone morphogenetic protein 4 (BMP4), EGF, or PDGF was un

137 Consequently, bone morphogenetic protein 4 (BMP4), or ectopic expressi

138 own to promote beta-cell function, including bone morphogenetic protein 4 (BMP4).

139 e been identified, including sonic hedgehog, bone morphogenetic protein 4 and multiple members of the

140 Contributions of bone morphogenetic protein 4 and transforming growth fac

141 le protocol, using defined medium containing bone morphogenetic protein 4 by which human pluripotent

142 Bone morphogenetic protein 4 up-regulated alphaB-crystal

143 e framework whereby activation of TGF-beta2, bone morphogenetic protein 4, Wnt/beta-catenin, or immun

144 Bone morphogenetic protein 6 (BMP6) contributes to the i

145 Lack of either bone morphogenetic protein 6 (BMP6) or the BMP corecepto

146 Bone morphogenetic protein 6 (BMP6) signaling in hepatoc

147 gion containing an excellent candidate gene, Bone morphogenetic protein 6 (Bmp6).

148 ether these molecules intersect in vivo with bone morphogenetic protein 6 (BMP6)/mothers against deca

149 ivary gland fluid secretion, is regulated by bone morphogenetic protein 6.

150 ansforming growth factor beta (TGFbeta), and bone morphogenetic protein 7 (BMP7), CD1c(+) dendritic c

151 We further identify bone morphogenetic protein 7 as one of them.

152 VEGF-A, VEGF-C, VEGF-D, VEGF-A isoform 121, bone morphogenetic protein 7, macrophage colony-stimulat

153 sue into endocrine cell types by exposure to bone morphogenetic protein 7.

154 (drMM) in the presence of human recombinant bone morphogenetic protein 7/human recombinant fibroblas

155 cluding fibroblast growth factor 21 (FGF21), bone morphogenetic protein 8b (BMP8b), growth differenti

156 Two members of the TGFbeta family, bone morphogenetic protein 9 (BMP9) and BMP10, have been

157 T is caused by loss-of-function mutations in bone morphogenetic protein 9 (BMP9)-ALK1-Smad1/5/8 signa

158 r-like kinase 1 (ALK1), endoglin, Smad4, and bone morphogenetic protein 9 (BMP9).

159 T signaling did not significantly affect the bone morphogenetic protein activity.

160 Bone morphogenetic protein and activin membrane-bound in

161 in vitro, and we identified ligands for the bone morphogenetic protein and insulin pathways as proad

162 otein negatively regulates the activities of bone morphogenetic protein and phosphoinositide 3-kinase

163 To address whether elevated activities of bone morphogenetic protein and PI3K/AKT signaling pathwa

164 valves demonstrated activation of canonical bone morphogenetic protein and Wnt/beta-catenin signalin

165 lls (hESCs) have been routinely treated with bone morphogenetic protein and/or inhibitors of activin/

166 cardiogenic fate of CNC(kit) is regulated by bone morphogenetic protein antagonism, a signaling pathw

167 expression of the gene encoding mesenchymal bone morphogenetic protein antagonist, GREM1.

168 AT reduces cleavage of the hepcidin inducing bone morphogenetic protein co-receptor HJV via inhibitio

169 channels regulate release of the Drosophila bone morphogenetic protein Dpp in the developing fly win

170 ifferent levels of activity of the canonical bone morphogenetic protein effectors SMAD1/5.

171 Treatment with bone morphogenetic protein or SHH pathway inhibitors dec

172 GDF7 (rs3072), which encodes a ligand in the bone morphogenetic protein pathway, and TBX5 (rs2701108)

173 We analyzed the effect of Irf8 on TGF-beta/bone morphogenetic protein pathway-specific genes in DCs

174 hrough a nuclear factor kappaB/interleukin 6/bone morphogenetic protein pathway.

175 /or cocaine due to severe down-modulation of bone morphogenetic protein receptor (BMPR) axis: the ant

176 ce suggests that serotonin, mutations in the bone morphogenetic protein receptor (BMPR) II gene, and

177 e mutations leading to reduced expression of bone morphogenetic protein receptor (BMPR) II, these mut

178 The effect of a mutation in the bone morphogenetic protein receptor 2 (BMPR2) gene on ri

179 Because decreased expression and function of bone morphogenetic protein receptor 2 (BMPR2) is observe

180 terized by endothelial dysfunction, impaired bone morphogenetic protein receptor 2 (BMPR2) signaling,

181 inked to a mutation or reduced expression of bone morphogenetic protein receptor 2 (BMPR2).

182 g displays increased aromatase and decreased bone morphogenetic protein receptor 2 and Id1 expression

183 pproximately 20% concurrence of inactivating bone morphogenetic protein receptor 2 mutations and dela

184 Anastrozole treatment reversed the impaired bone morphogenetic protein receptor 2 pathway in females

185 expression may play a protective role in the bone morphogenetic protein receptor 2 unaffected carrier

186 itable PAH), most often through mutations of bone morphogenetic protein receptor 2, and idiopathic an

187 with hyperactivating mutations of the type I bone morphogenetic protein receptor ACVR1 (Activin type

188 zol-2-yl)benzamide] but not the inhibitor of bone morphogenetic protein receptor dorsomorphin, blocke

189 HT), which is caused by mutations in TGFbeta/bone morphogenetic protein receptor genes, ENG, encoding

190 However, transforming growth factor beta and bone morphogenetic protein receptor II signaling, and hy

191 role of transforming growth factor beta and bone morphogenetic protein receptor II signaling, human

192 ifferential transforming growth factor beta, bone morphogenetic protein receptor II signaling, or car

193 t beta1-integrin directly interacts with the bone morphogenetic protein receptor subunits BMPR1a and

194 Expression of bone morphogenetic protein receptor type 2 (BMPR2) and i

195 erozygous mutations in the gene encoding the bone morphogenetic protein receptor type 2 (BMPR2) are t

196 ith heritable PAH caused by mutations in the bone morphogenetic protein receptor type 2 (BMPR2) gene

197 l hypertension with germline mutation in the bone morphogenetic protein receptor type 2 (BMPR2) gene,

198 H (HPAH) is often caused by mutations in the bone morphogenetic protein receptor type 2 gene (BMPR2).

199 despite clinical and molecular similarity to bone morphogenetic protein receptor type 2 mutation-asso

200 Mutations in the gene encoding the bone morphogenetic protein receptor type II (BMPR2) are

201 Since the landmark discovery that bone morphogenetic protein receptor type II (BMPR2) muta

202 duced aggregation; 2) rs11202221, in BMPR1A (bone morphogenetic protein receptor type1A), replicated

203 rphogenetic proteins through VE-cadherin and bone morphogenetic protein receptor-II/Smad5.

204 In addition, the reduction in bone morphogenetic protein signaling and Shotgun express

205 ranase greatly stimulated chondrogenesis and bone morphogenetic protein signaling as revealed by Smad

206 However, inhibition of bone morphogenetic protein signaling caused a significan

207 nal profiling of isolated nail LRCs revealed bone morphogenetic protein signaling favors nail differe

208 eveal a novel role of TCF7l2 in repressing a bone morphogenetic protein signaling pathway that is kno

209 (Wnt), transforming growth factor-beta, and bone morphogenetic protein signaling pathways affect car

210 specific target genes upon Shh, retinoid, or bone morphogenetic protein signaling, and the collocatio

211 aranase is able to stimulate chondrogenesis, bone morphogenetic protein signaling, cell migration, an

212 Genes associated with bone morphogenetic protein signaling, such as bmp2, nog,

213 R/MEK/Erk1/2 signaling and downregulation of bone morphogenetic protein signaling, with negative and

214 ed either by erythroferrone or by inhibiting bone morphogenetic protein signaling.

215 8ORF1 could block TGF-beta signaling but not bone morphogenetic protein signaling.

216 showed that loss of PEAT modestly increases bone morphogenetic protein target gene expression and al

217 fferentially expressed genes were related to bone morphogenetic protein type 2 receptor (BMPR2) signa

218 ty of HPAH patients inherit mutations in the bone morphogenetic protein type 2 receptor gene (BMPR2),

219 Genetic evidence implicates the loss of bone morphogenetic protein type II receptor (BMPR-II) si

220 phagy and block lysosomal degradation of the bone morphogenetic protein type II receptor (BMPR-II), m

221 Mutations in the bone morphogenetic protein type-II receptor (BMPR-II) ar

222 Heterozygous germ-line mutations in the bone morphogenetic protein type-II receptor (BMPR-II) ge

223 ntiation and new bone formation through WNT, bone morphogenetic protein, and Notch signaling pathways

224 ation of Hedgehog, fibroblast growth factor, bone morphogenetic protein, and Wnt signaling in the gen

225 , Indian hedgehog, fibroblast growth factor, bone morphogenetic protein, and Wnt signaling pathways i

226 ignaling pathways, including Sonic hedgehog, bone morphogenetic protein, fibroblast growth factor, tr

227 niche signalling pathways, specifically Wnt, bone morphogenetic protein, Notch and epidermal growth f

228 about Notch, transforming growth factor beta/bone morphogenetic protein, Ras, mitogen-activated prote

229 e to maintain pluripotency in the absence of bone morphogenetic protein, removal of LIF destabilizes

230 The four members of the family: bone morphogenetic protein-1 (BMP-1), mammalian tolloid

231 lial growth factor A (VEGFA), interleukin-2, bone morphogenetic protein-10, VEGFC, and 2 (FGF2) were

232 st differentiation promoted and sustained by bone morphogenetic protein-2 (BMP-2) and TGF-beta, respe

233 rently, sustained in vivo delivery of active bone morphogenetic protein-2 (BMP-2) protein to responsi

234 ch as fibroblast growth factor-2 (FGF-2) and bone morphogenetic protein-2 (BMP-2) work synergisticall

235 ECFCs produced bone morphogenetic protein-2 (BMP-2), a potent osteoindu

236 gulates differentiation of OCs downstream of bone morphogenetic protein-2 (BMP-2)-stimulated osteobla

237 l with a collagen scaffold soaked in saline, bone morphogenetic protein-2 (BMP-2; 200 ng), 1 muM CGS2

238 al and temporal release of recombinant human bone morphogenetic protein-2 (BMP2) and vascular endothe

239 Although bone morphogenetic protein-2 (BMP2) has demonstrated ext

240 on of mesenchymal stem cells (MSCs), whereas bone morphogenetic protein-2 (BMP2) promotes osteogenic

241 ayer coating carrying as little as 200 ng of bone morphogenetic protein-2 and platelet-derived growth

242 In osteoblasts, CypA is necessary for BMP-2 (Bone Morphogenetic Protein-2)-induced Smad phosphorylati

243 In the present study, bone morphogenetic protein-2/BMP-2-directed osteogenic d

244 Bone morphogenetic protein-4 (BMP4) plays a key role in

245 es for hESC differentiated to TB by means of bone morphogenetic protein-4 and inhibitors of activin A

246 fragment was identified to bind to the human bone morphogenetic protein-6 (hBMP6) growth factor and c

247 echanisms involved revealed the induction of bone morphogenetic protein-7 (BMP7) expression, a critic

248 Bone morphogenetic protein-7 (BMP7) is an antifibrotic c

249 We evaluated the effects of THR-184, a bone morphogenetic protein-7 agonist, in patients at hig

250 Our objective is to determine circulating Bone morphogenetic protein-9(BMP-9) levels in subjects w

251 l vein forms and expands ventrally through a Bone Morphogenetic Protein-dependent step of collective

252 ilarly, wild-type (WT) animals, in which the bone morphogenetic protein-mothers against decapentapleg

253 ar stress driven and downstream of canonical bone morphogenetic protein-SMAD signaling.

254 ic stress induces p57Kip2 expression via the bone morphogenetic protein-Smad1 and Atm-p38MAPK-Atf2 pa

255 es with sLR11 inhibits thermogenesis via the bone morphogenetic protein/TGFbeta signalling pathway an

256 Exogenous bone morphogenetic proteins (Bmp) are well known to indu

257 subgroup of the TGFbeta superfamily are the bone morphogenetic proteins (BMP), but the effects of BM

258 Bone morphogenetic proteins (BMP), part of the TGFbeta s

259 thelial serine-threonine kinase receptor for bone morphogenetic proteins (BMPs) 9 and 10.

260 Bone morphogenetic proteins (BMPs) act in dose-dependent

261 glands are specified by mesenchymal-derived bone morphogenetic proteins (BMPs) and fibroblast growth

262 Bone morphogenetic proteins (BMPs) are antagonized throu

263 Bone morphogenetic proteins (BMPs) are growth factors th

264 Bone morphogenetic proteins (BMPs) are members of the tr

265 Bone morphogenetic proteins (BMPs) are members of the tr

266 Bone morphogenetic proteins (BMPs) are secreted cytokine

267 Bone morphogenetic proteins (BMPs) are secreted growth f

268 Bone morphogenetic proteins (BMPs) are TGF-beta family m

269 Since the discovery of bone morphogenetic proteins (BMPs) as pluripotent cytoki

270 mbryo is regulated by graded distribution of bone morphogenetic proteins (BMPs) composed of two ligan

271 Subsequent treatment with bone morphogenetic proteins (BMPs) enhanced differentiat

272 Bone morphogenetic proteins (BMPs) have unexpectedly div

273 In Xenopus laevis, bone morphogenetic proteins (Bmps) induce expression of

274 Bone morphogenetic proteins (BMPs) instruct NSCs to adop

275 rcomes the inhibitory effect of lung-derived bone morphogenetic proteins (BMPs) on self-renewal and t

276 Bone morphogenetic proteins (BMPs) orchestrate key cellu

277 Bone Morphogenetic Proteins (BMPs) pattern the dorsal-ve

278 Bone morphogenetic proteins (BMPs) play key roles in the

279 Bone morphogenetic proteins (BMPs) play vital roles in r

280 Bone morphogenetic proteins (BMPs) regulate diverse cell

281 Bone morphogenetic proteins (BMPs) show promise in thera

282 Noggin is a specific antagonist of bone morphogenetic proteins (BMPs) that can prevent the

283 anoid cultures, such as those involving Wnt, bone morphogenetic proteins (BMPs), Notch, and Hedgehog

284 ignaling by Sonic hedgehog (SHH) followed by Bone morphogenetic proteins (BMPs), regulate a dynamic e

285 d in the nervous system as a co-receptor for bone morphogenetic proteins (BMPs).

286 fferentiate into preosteoblasts that produce bone morphogenetic proteins (BMPs).

287 Bone morphogenetic proteins 4 and 7 (BMP4 and BMP7) are

288 nd subsequent transcriptional suppression of bone morphogenetic proteins 5 and 7.

289 rogeneous, congenital heart diseases, and to bone morphogenetic proteins 7 as an effective treatment

290 hat supplementation of exogenous recombinant bone morphogenetic proteins 7 effectively ameliorates en

291 Bone morphogenetic proteins 9 and 10 (BMP9/BMP10) are ci

292 operate locally (e.g., Wingless/Ints [Wnts], Bone Morphogenetic Proteins [BMPs], and Hedgehogs [Hhs])

293 lated by Sonic hedgehog (Shh), retinoids, or bone morphogenetic proteins in the CNS, we provide evide

294 dysregulated transforming growth factor beta/bone morphogenetic proteins signaling and that this imba

295 ing, and that ligandless activity in the TGF/bone morphogenetic proteins signaling pathway contribute

296 phosphorylation was mediated by SMC-released bone morphogenetic proteins through VE-cadherin and bone

297 ease inhibitor that binds growth factors and bone morphogenetic proteins, has nonsynonymous changes f

298 yelin-forming oligodendrocytes is limited by bone morphogenetic proteins, which constitute one arm of

299 53 activation; THR-184, a peptide agonist of bone morphogenetic proteins; removal of catalytic iron,

300 Although mutations in the bone morphogenetic receptor 2 (BMPR2) are found in 80% o